NewAmsterdam Pharma Co NV
NewAmsterdam Pharma Co NV operates in Diversified Metals & Mining.
Market Cap & Net Worth: NewAmsterdam Pharma Co NV (KH6)
NewAmsterdam Pharma Co NV (DU:KH6) has a market capitalization of $271.71K (€264.70K) as of March 19, 2026. Listed on the DU stock exchange, this Germany-based company holds position #38742 globally and #5341 in its home market, demonstrating a 4.69% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NewAmsterdam Pharma Co NV's stock price €26.80 by its total outstanding shares 9877 (9.88K).
NewAmsterdam Pharma Co NV Market Cap History: 2024 to 2026
NewAmsterdam Pharma Co NV's market capitalization history from 2024 to 2026. Data shows growth from $245.35K to $271.71K (27.44% CAGR).
NewAmsterdam Pharma Co NV Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NewAmsterdam Pharma Co NV's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of KH6 by Market Capitalization
Companies near NewAmsterdam Pharma Co NV in the global market cap rankings as of March 19, 2026.
Key companies related to NewAmsterdam Pharma Co NV by market ranking:
- BERKSHIRE HATH-A (BE:BRH): Ranked #2400 globally with a market cap of $6.13 Billion USD ( €5.98 Billion EUR).
- BERKSHIRE HATH-A - Dusseldorf Stock Exchang (DU:BRH): Ranked #2412 globally with a market cap of $6.09 Billion USD ( €5.94 Billion EUR).
- Itissalat Al-Maghrib (IAM) S.A (PINK:MAOTF): Ranked #3752 globally with a market cap of $3.25 Billion USD.
- NET ONE SYSTEMS (MU:NOX): Ranked #4657 globally with a market cap of $2.24 Billion USD ( €2.18 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2400 | BERKSHIRE HATH-A | BE:BRH | $6.13 Billion | €634500.00 |
| #2412 | BERKSHIRE HATH-A - Dusseldorf Stock Exchang | DU:BRH | $6.09 Billion | €638000.00 |
| #3752 | Itissalat Al-Maghrib (IAM) S.A | PINK:MAOTF | $3.25 Billion | $14.80 |
| #4657 | NET ONE SYSTEMS | MU:NOX | $2.24 Billion | €1000000.00 |
NewAmsterdam Pharma Co NV Historical Marketcap From 2024 to 2026
Between 2024 and today, NewAmsterdam Pharma Co NV's market cap moved from $245.35K to $ 271.71K, with a yearly change of 27.44%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €271.71K | -9.46% |
| 2025 | €300.10K | +22.31% |
| 2024 | €245.35K | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of NewAmsterdam Pharma Co NV was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $271.71K USD |
| MoneyControl | $271.71K USD |
| MarketWatch | $271.71K USD |
| marketcap.company | $271.71K USD |
| Reuters | $271.71K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.